Patents by Inventor Stephanie Volz

Stephanie Volz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • miRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20140274791
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MIRNA BIOMARKERS OF PROSTATE DISEASE
    Publication number: 20140235469
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Application
    Filed: October 28, 2013
    Publication date: August 21, 2014
    Applicant: ASURAGEN, INC.
    Inventors: Jeffrey SHELTON, Kevin KELNAR, Stephanie VOLZ, Alex ADAI, David BROWN
  • MiRNA biomarkers of lung disease
    Patent number: 8735074
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: May 27, 2014
    Assignee: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MiRNA biomarkers of prostate disease
    Patent number: 8597892
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: December 3, 2013
    Assignee: Asuragen, Inc.
    Inventors: Jeffrey Shelton, Kevin Kelnar, Stephanie Volz, Alex Adai, David Brown
  • MIRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20110053158
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 3, 2011
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth MAMBO, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MIRNA BIOMARKERS OF PROSTATE DISEASE
    Publication number: 20100297652
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Application
    Filed: May 21, 2010
    Publication date: November 25, 2010
    Applicant: Asuragen, Inc.
    Inventors: Jeffrey Shelton, Kevin Kelnar, Stephanie Volz, Alex Adai, David Brown
  • Methods and Compositions Involving miRNAs In Cancer Stem Cells
    Publication number: 20100179213
    Abstract: The present invention concerns methods and compositions for treating a patient having, suspected of having, or at risk of developing cancer by targeting cancer stem cells.
    Type: Application
    Filed: November 11, 2009
    Publication date: July 15, 2010
    Applicants: MIRNA THERAPEUTICS, INC., The Board of Regents of the University of Texas System
    Inventors: Lubna Patrawala, Dean G. Tang, Kevin Kelnar, Jason Wiggins, Stephanie Volz, Jeffrey Shelton, Can Liu, Andreas G. Bader, David Brown